Navigation Links
Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Date:10/3/2007

PORTLAND, Ore., Oct. 3 /PRNewswire/ -- Virogenomics, Inc. today announced that the company has been awarded a $2 million grant from the National Institute of Standards and Technology (NIST) to develop a Sensor System on Panel (SSOP) that tests for many different biological markers in a single assay.

Successful development of the SSOP could revolutionize research on and the diagnosis of multifactorial conditions such as autoimmune disease and allergy, enabling earlier treatment and the development of more specific therapeutics.

Medical diagnostic methods typically test for a single "biomarker" that indicates a possible disease state. This approach provides only limited information because many diseases have multiple contributing factors and surrogate markers of interest. For that reason a single test can never provide a complete diagnosis. Autoimmune diseases, allergies, cancers, and infectious diseases can have many different causes and manifestations, and could be better diagnosed with devices that can test for many different markers in a single assay. Virogenomics has proposed developing such a device using transducers made with existing microelectronic manufacturing methods and is based on technology licensed from Oregon Health & Science University.

The proposed Sensor System on Panel (SSOP) will include all the hardware and firmware required to do a complete analysis of the interaction of biological molecules and communicate the result. The SSOP will incorporate at least two types of transducers and several transducer sub-types as well as circuit elements for command and control functions. Each sensor will have many transducers, each with a specific protein attached. When a patient sample, either serum or saliva, is applied to the device, the SSOP will detect any proteins that bind to any of the proteins attached to the transducers. The device would be the size and shape of a typical USB flash drive, and could be read on a standard perso
'/>"/>

SOURCE Virogenomics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
2. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
3. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
9. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
10. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
11. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2008)...HESTER, Minn., Nov. 26 ...rd are at significantly increased risk of developi... findings of a Mayo Clinic study published this m...merican Academy of Pediatrics. , , The retr...7 patients with strabismus (misaligned eyes) and c...
(Date:11/26/2008)...dy Expanded to 406 Subjects , , FRANKLIN, M...s Inc. (OTC Bulletin Board: PLCSF) announced today...Food and Drug Administration (FDA) for its U.S. pi...any,s RenalGuard System(TM) and associated therap...y (CIN). , , The FDA also approved PLC,s re...
(Date:11/25/2008)...ISVILLE, Ky., Nov. 25 K...urgeons performed the fifth U.S. hand transplant o... at Louisville,s Jewish Hospital Hand Care Center ...began around noon and was completed shortly after ... http://www.newscom.com/cgi-bin/prnh/20081125/DC4...
(Date:11/25/2008)...TH SAN FRANCISCO, Calif., Nov. 25 ...velopment of novel therapeutics that target,prote...iseases, today,announced that data from two ongoi...iple myeloma will be presented at the upcoming 50t...ology (ASH). Carfilzomib is the first in a new cl...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 1Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 2Leading Worldwide Cause of Cardiovascular Disease May Be Modified by Diet 23346 3Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 23343 1Rocker Joel Madden Named Newest UNICEF Goodwill Ambassador 23343 2Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference 23340 1Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference 23340 2Physicians Practice Promotes Key Executives 23337 1Physicians Practice Promotes Key Executives 23337 2
...t Randomized, Placebo-controlled Trial,Ever Conduc...linical Oncology, CHICAGO, June 04, 2007 /PRNewswi...ed, placebo-controlled clinical trial ever,conduct...L) showed,that ONTAK was more than twice as effect... patients with CTCL. [Abstract number 8026],The pr...
...With Follicular Lymphoma Reported,Today at ASCO An...ire/ -- GlaxoSmithKline plc,announced today long-t...e one-week course of frontline treatment with the ...ine I-131 Tositumomab) in,76 patients with newly d...a (NHL). This regimen was found to induce durable ...
Other Medicine Technology:Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
(Date:12/2/2008)...orld Wide Dictation Service, one of the premier le...ption, and legal dictation transcription, has joi... non-profit organization geared to the betterment ...amilies throughout Lower Westchester County, New Y...) December 3, 2008 -- World Wide Dictation Service...
(Date:12/2/2008)...oes your over-the-phone interpretation vendor cont...completed the call? , Was...orld of over-the-phone interpretation (OPI), every...er one minute can add up over the course of a bill...ganization employs an over-the-phone interpretatio...
(Date:12/2/2008)...rion Health announces that the SouthEast Alaska Re...a, has selected the Rhapsody™ Integration En...d, radiology, pharmacy, laboratory and business pr...to extend connectivity to statewide systems such a...ry) and AKAIMS (an MIS and clinical documentation ...
(Date:12/1/2008)... Including a patient,s ...meticulous reading from the radiologist interpreti...thetic approach, according to a study presented to...ety of North America (RSNA). , , "Our stud...ing and not as an anonymous case study," said lead...
Breaking Medicine News(10 mins):Health News:World Wide Dictation Service Teams up with TMATT for Local Thanksgiving Community Dinner 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 2Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 3
...ntified particular genes that are most prone to be...alled DNA promoter hypermethylation. Hypermethyla... normal cell development, to generate proteins tha...ehavior, or unregulated cell growth. So far, dat...
... between an extreme form of sleep disorder, REM Be...tia or parkinsonism. Patients with RBD have a hi...tia, Parkinsons disease or multiple system atrophy...pear to stem from a similar neurodegenerative orig...
...iasts and experts in the capital are strongly oppo...ng to recent reports of yet another application fi...l that the very idea of patenting knowledge like y..."Patenting of any kind is highly unjustified and w...
...age for mental illness does not increase usage and...who have children with mental illness, a Yale Scho... Services Research. Prior research has left polic...te parity laws will neither break the bank nor con...
Other Medicine News:Health News:Researchers Have Identified Cancer Promoter Genes 2Health News:Researchers Find Link Between Sleep Disorder and Dementia 2Health News:Yoga Enthusiasts Oppose Patenting Yoga Overseas 2Health News:Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending 2
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work.
Near PT test card/child recog/ playing cards 5 1/2" X 8".
Near point card/newspaper 8 to 48 point type 5 1/2" X 8".
Near point card 4 1/2 to 24 PT 5 1/2" x 8".
Medicine Products: